Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles

Journal of Drug Targeting

Volumn 19, Issue 3, 2011, Pages 228-234

  Chen, Wei ^a,b   Zhan, Changyou ^b   Gu, Bing ^b   Meng, Qinggang ^b   Wang, Hao ^c   Lu, Weiyue ^b   Hou, Huimin ^c  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b FUDAN UNIVERSITY   (China)

^c National Pharmaceutical Engineering and Research Center   (China)

Author keywords

albumin nanoparticles; Brain targeting; in vitro and in vivo; itraconazole; RVG

Indexed keywords

ALBUMIN; BIOTIN; CYCLODEXTRIN; ITRACONAZOLE; NANOPARTICLE; RABIES VIRUS GLYCOPROTEIN 29; STREPTAVIDIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG TARGETING; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIGHT SCATTERING; MALE; MOUSE; MYCOSIS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RAT; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

ANIMALS; ANTIGENS, VIRAL; BIOTIN; BLOOD-BRAIN BARRIER; BRAIN; CYCLODEXTRINS; DRUG CARRIERS; DRUG COMPOUNDING; ENDOTHELIAL CELLS; EXCIPIENTS; GLYCOPROTEINS; HUMANS; ITRACONAZOLE; MALE; MICE; NANOPARTICLES; PARTICLE SIZE; PEPTIDE FRAGMENTS; RATS; SERUM ALBUMIN; SUSPENSIONS; VIRAL ENVELOPE PROTEINS;

EID: 79952673009     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.492523     Document Type: Article

References (26)

1. Al-Abdely HM, Najvar LK, Bocanegra R, Graybill JR. (2005). Antifungal therapy of experimental cerebral phaeohyphomycosis due to Cladophialophora bantiana. Antimicrob Agents Chemother, 49, 1701-1707. (Pubitemid 40631577)
2. Bartus RT, Elliott PJ, Dean RL, Hayward NJ, Nagle TL, Huf MR, Snodgrass PA, Blunt DG. (1996). Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7. Exp Neurol, 142, 14-28. (Pubitemid 26381377)
3. Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. (2007). Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev, 59, 454-477. (Pubitemid 47259226)
4. Bradbury MW. (1985). Te blood-brain barrier. Transport across the cerebral endothelium. Circ Res, 57, 213-222. (Pubitemid 15247777)
5. Broadwell RD. (1989). Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal. Acta Neuropathol, 79, 117-128. (Pubitemid 19286136)
6. Chen W, Gu B, Wang H, Pan J, Lu W, Hou H. (2008). Development and evaluation of novel itraconazole-loaded intravenous nanoparticles. Int J Pharm, 362, 133-140.
7. De Boer AG, Gaillard PJ. (2007). Drug targeting to the brain. Annu Rev Pharmacol Toxicol, 47, 323-355.
8. Gotti C, Clementi F. (2004). Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol, 74, 363-396. (Pubitemid 40092737)
9. Kang YS, Saito Y, Pardridge WM. (1995). Pharmacokinetics of [3H] biotin bound to diferent avidin analogues. J Drug Target, 3, 159-165.
10. Kreuter J. (2001). Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev, 47, 65-81. (Pubitemid 32209233)
11. Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, Pathak K. (2008). Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm, 358, 285-291.
12. Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL, Lee SK, Shankar P, Manjunath N. (2007). Transvascular delivery of small interfering RNA to the central nervous system. Nature, 448, 39-43. (Pubitemid 47037001)
13. Lafon M. (2005). Rabies virus receptors. J Neurovirol, 11, 82-87. (Pubitemid 40458377)
14. Lee MK, Lim SJ, Kim CK. (2007). Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials, 28, 2137-2146.
15. Lentz TL. (1990). Rabies virus binding to an acetylcholine receptor alpha-subunit peptide. J Mol Recognit, 3, 82-88.
16. Lentz TL, Burrage TG, Smith AL, Crick J, Tignor GH. (1982). Is the acetylcholine receptor a rabies virus receptor? Science, 215, 182-184. (Pubitemid 12178107)
17. Liu Y, Huang R, Han L, Ke W, Shao K, Ye L, Lou J, Jiang C. (2009). Brain-targeting gene delivery and cellular internalization mechanisms for modifed rabies virus glycoprotein RVG29 nanoparticles. Biomaterials, 30, 4195-4202.
18. Mishra V, Mahor S, Rawat A, Gupta PN, Dubey P, Khatri K, Vyas SP. (2006). Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J Drug Target, 14, 45-53.
19. Nobs L, Buchegger F, Gurny R, Allémann E. (2006). Biodegradable nanoparticles for direct or two-step tumor immunotargeting. Bioconjug Chem, 17, 139-145. (Pubitemid 43157595)
20. Schnyder A, Krähenbühl S, Drewe J, Huwyler J. (2005). Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological efects. J Drug Target, 13, 325-335. (Pubitemid 41283166)
21. Tosi G, Costantino L, Rivasi F, Ruozi B, Leo E, Vergoni AV, Tacchi R, Bertolini A, Vandelli MA, Forni F. (2007). Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. J Control Release, 122, 1-9. (Pubitemid 47284547)
22. Townsend SA, Evrony GD, Gu FX, Schulz MP, Brown RH Jr, Langer R. (2007). Tetanus toxin C fragment-conjugated nanoparticles for targeted drug delivery to neurons. Biomaterials, 28, 5176-5184. (Pubitemid 47488499)
23. Turgut M, Ozsunar Y, Oncü S, Akyüz O, Ertugrul MB, Tekin C, Gültekin B, Sakarya S. (2008). Invasive fungal granuloma of the brain caused by Aspergillus fumigatus: a case report and review of the literature. Surg Neurol, 69, 169-74; discussion 174. (Pubitemid 351186711)
24. Weiss B, Schneider M, Muys L, Taetz S, Neumann D, Schaefer UF, Lehr CM. (2007). Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-co- glycolide) nanoparticles for versatile surface modifcation. Bioconjug Chem, 18, 1087-1094. (Pubitemid 47122628)
25. Wong JW, Nisar UR, Yuen KH. (2003). Liquid chromatographic method for the determination of plasma itraconazole and its hydroxyl metabolite in pharmacokinetic/bioavailability studies. J Chromatography B, 798, 335-360.
26. Xia CF, Boado RJ, Pardridge WM. (2009). Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology. Mol Pharm, 6, 747-751.